The day-to-day operational management is overseen by the Steering Committee (SC)
The SC consists of (since April 2024) :
- Philip Timmerman, also acting as Chairman of the EBF vzw
- Stephen White, GSK
- Kyra Cowan, Merck KGaA
- Matthew Barfield, F. Hoffmann La Roche
- Robert Nelson, BioAgilytix
- Michaela Golob, Nuvisan GmbH